Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug-drug Interaction Study to Evaluate the Pharmacokinetics and Safety of FYU-981 and Oxaprozin in Healthy Male Adults Subjects

NCT03350386 is registered in ClinicalTrials.gov with Mochida Pharmaceutical Company, Ltd. as lead sponsor.

NCT NCT03350386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03350386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug-drug Interaction Study to Evaluate the Pharmacokinetics and Safety of FYU-981 and Oxaprozin in Healthy Male Adults Subjects
Lead sponsor
Mochida Pharmaceutical Company, Ltd.
Phase
Phase 1
Overall status
Completed
Start date
November 2, 2017
Completion date
December 5, 2017
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy